Medical Cannabis
Overdue ACMD Report Gets New Deadline as Industry Weighs In
By Ben Stevens, with additional reporting by Nicole Farah, Managing Director of Americana Communications.
Dalgety
9stories
23 Septlast updated
More in Dalgety
- Uncategorized
Dalgety Doubles Down on UK-Grown Cannabis With Three New Strains and £8M Expansion Drive
Having done the legwork over the last five years to build a state-of-the-art 30,000sq ft indoor growing facility, and secure licencing to cultivate, manufacture and supply medical cannabis flower from its facility, Dalgety is wasting no time in ramping up its operations.
- Opinion
What’s in Store for the European Cannabis Industry in 2025? (Part 2)
Written by Ben Stevens and Sarah Sinclair. You can read Part 1 here.
- Press releases
Dalgety Secures EU-GMP Certification and Upgraded Home Office License
Dalgety has become one of two leading medical cannabis cultivators in the UK to be granted a Home Office licence to supply in the UK alongside a full EU-GMP certification.
- Markets & Stocks
Tilray Gets First New German Domestic Cultivation Licence, Dalgety Seeks £6m Investment, & More from Celadon
Tilray [stock_market_widget type=”chart” template=”line” assets=”TLRY” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] US cannabis giant Tilray has become the first company in half a decade to recieve a new domestic cannabis cultivation licence in Germany.
- Press releases
Calls for More Industry Transparency as Medical Cannabis Producer Reveals High Yield
Leading UK medical cannabis producer Dalgety has, for the first time, revealed its impressive yield while calling for more industry transparency across the UK market.
